CheckMyRecalls

Unichem Pharmaceuticals USA Inc. recalls Bisoprolol Fumarate and…

Unichem Pharmaceuticals USA Inc. recalls Bisoprolol Fumarate and Hydrochlorothiazide tablets

Published
11 Feb 2026
Units affected
N/A
Agency
FDA
Country
United States

The hazard

CGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01

Brand / company
Unichem Pharmaceuticals USA Inc.
Codes / lots
Lot # GBHL24005A, Exp Date: 09/2026
Distribution
US Nationwide and PR.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 11 Feb 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.